RASAL2 and renal cell carcinoma: Performing gain-of-function and loss-of-function studies, Hui et al. demonstrated that formation of new blood vessels was suppressed by RASAL2 via VEGFA downregulation in renal cell carcinoma metastasis (Hui et al. 2018).